Skip to Content
Søg Menu
2023

Få seneste nyt fra EHA – Se MEDtalks og læs artikler

Seneste nyt fra EHA 2023

Carsten Niemann

Overlevelsesgevinst for skrøbelige CLL-patienter i behandling med Imbruvica og Venclyxto

/ Carsten Utoft Niemann
EHA23CLL Play the Video

Epcoritamab with Rituximab and Lenalidomide (R2) for Patients with High-Risk Follicular Lymphoma

/ Hæmatologi / Anna Sureda Balari

Gilteritinib for patients with newly diagnosed AML

/ Hæmatologi / Mark Levis

MURANO study supports the use of fixed-duration VenR in R/R CLL

/ Hæmatologi / Arnon Kater

Daratumumab Combination Shows Positive Responses in Pretreated R/R Multiple Myeloma

/ Hæmatologi / Evangelos Terpos

News from EHA23 – A Promising Treatment Option for Follicular Lymphoma

/ Hæmatologi / Ryan Jacobs

What is new from EHA23 regarding treatment Strategies in First-Line CLL?

/ Hæmatologi / Barbara Eichhorst
Eva Futtrup Maksten

Risk of dementia in older patients treated with chemotherapy for lymphoma

/ Eva Futtrup Maksten
EHA23LymfomDemens Play the Video

Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment

/ Evangelos Terpos / Jan Andreasen
EHA23Myelomatose
Alan Z. Skarbnik

New Research from EHA23 Points to Similar Effectiveness of Acalabrutinib and Zanubrutinib in R/R CLL Treatment

/ Alan Z. Skarbnik
EHA23CLL Play the Video
Dima El-sharkawi

UK Trial Gives Voice to CLL Patients’ Experiences with Targeted Therapies

/ Dima El-Sharkawi
EHA23CLL Play the Video
Martin Hutchings

Promising Findings for R/R Large B-cell Lymphoma – Glofitama and Epcoritamab Show Curative Potential

/ Martin Hutchings
ASCO23EHA23Lymfom Play the Video
Carsten Niemann

MURANO 7-års data viser fortsat effekt ved R/R CLL – men giver ikke svar på alle spørgsmål

/ Carsten Utoft Niemann
EHA23CLL Play the Video
Emelie Hamotal Curovic Rotbain

Dansk/amerikansk studie viser øget dødelighed for patienter med CLL og type 2-diabetes

/ Emelie Hamotal Curovic Rotbain
EHA23Infertilitet Play the Video
Othman Al-Sawaf

New CLL Study Supports Inclusion of Venetoclax Plus Obinutuzumab in Treatment Guidelines

/ Othman Al-sawaf
EHA23CLL Play the Video
Carsten Niemann

CLL14-studiet er tæt på overlevelsesgevinst for skrøbelige patienter med CLL

/ Carsten Utoft Niemann
EHA23CLL Play the Video
Hent flere

Onkologi/Hæmatologi • Nr. 10 • 2023

  • LAG3-hæmmere ændrer immunterapiens behandlingslandskab
  • Highlights fra ASCO GI & GU
  • Highlights fra ASH 2022
  • Myelomatose: Geografisk betinget? 
Get access

Højdepunkter fra EHA webinar 2022

Martin Hutchings

Hidtil højeste overall survival udfordrer 1.-linjebehandling ved Hodgkin lymfom

/ Martin Hutchings
Lymfom Play the Video
Martin Hutchings

To bispecifikke antistoffer er på vej mod godkendelse mod diffust storcellet B-celle lymfom

/ Martin Hutchings
Lymfom Play the Video
Carsten Utoft Niemann

Tidsbegrænset venetoclax-baseret kombinationsbehandling opnår bedre PFS og MRD-negativitet ved behandling af CLL

/ Carsten Utoft Niemann
CLL Play the Video
Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video

MEDtalks fra EHA 2022

AML

FLT3 Inhibitor Gilteritinib Shows Potential in Post-Transplant Maintenance for AML

/ Hæmatologi / Mark Levis

Treatment Options for FLT3 mutant acute myeloid leukemia

/ Hæmatologi / Eunice Wang

UK NCRI AML19 Trial – Liposomal daunorubicin and cytarabine had a significant survival benefit

/ Hæmatologi / Jad Othman

AML patients with FLT3-ITD and wild-type NPM1 has a significant improvement of LFS, OS and GRFS

/ Hæmatologi / Ali Bazarbachi

AML-highlights fra ASH22 – i dansk perspektiv

/ Hæmatologi / Hans Beier Ommen
Se oversigt

CLL

Ibrutinib + venetoclax: Ny behandlingsmulighed ved CLL behandling i første linje

/ Hæmatologi / Carsten Utoft Niemann

CRTH award winning study demonstrates malignancy risks for CLL patients

/ Hæmatologi / Thomas Chatzikonstantinou

Acalabrutinib Shows Lower Cardiac Failure Rates Than Ibrutinib in CLL Treatment

/ Hæmatologi / Paolo Ghia

Nyt studie sammenligner BTK-hæmmere til behandling af R/R CLL

/ Hæmatologi / Carsten Utoft Niemann

Ny behandlingsmulighed for patienter med R/R CLL

/ Hæmatologi / Carsten Utoft Niemann
Se oversigt

Lymfom

Therapeutic options for patients with primary refractory or early relapsed DLBCL

/ Hæmatologi / Manali Kamdar

Axicabtagene ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients

/ Hæmatologi / Roch Houot

Evidence to use MRD after induction therapy of AML

/ Hæmatologi / Jacqueline Cloos

R/R Large B-cell Lymphoma: Interesting results from ASH 2022 for treatment with Yescarta (axicabtagene ciloleucel)

/ Hæmatologi / Frederick L. Locke

R/R AML: The benefit of intensive remission induction chemotherapy prior to allogeneic hematopoietic cell transplantation

/ Hæmatologi / Johannes Schetelig
Se oversigt

Myelomatose

EHA23 Insights into the Changing Landscape of Myeloma Treatments

/ Hæmatologi / Fredrik Schjesvold

Exciting News for CAR T Cell Therapy to Heavily Treated Patients with Multiple Myeloma

/ Hæmatologi / Sagar Lonial

Integrating BCMA-Based Combination Regimens in Early R/R Multiple Myeloma

/ Hæmatologi / Rakesh Popat

Updated results on AVO therapeutic triplet regimen in untreated patients with CLL

/ Hæmatologi / Christine Ryan

CLL – The impact of using ibrutinib as front-line treatment

/ Hæmatologi / Ryan Jacobs
Se oversigt

Abstracts fra EHA 2022

Ibrutinib keeps on delivering now as first-line treatment for older patients with mantle cell lymphoma

/ Hæmatologi / BestPractice Nordic

Superior safety profile for decitabine vs chemotherapy for older patient with AML

/ Hæmatologi / BestPractice Nordic

A novel CAR-T cell therapy thas proven highly effective for patients with RRMM

/ Hæmatologi / BestPractice Nordic

A new phase 3 trial shows significantly prolonged overall survival for patients with AML

/ Hæmatologi / BestPractice Nordic

Improved PFS is achievable using targeted therapy combinations with venetoclax in fit patients with treatment naïve CLL 

/ Hæmatologi / BestPractice Nordic

Treatment of Burkitt lymphoma with DA-EPOCH-R is associated with significant less infectious complications, transfusions, and hospitalization days 

  • / BestPractice Nordic

Se highlights EHA webinar 2022

Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video
Martin Hutchings

To bispecifikke antistoffer er på vej mod godkendelse mod diffust storcellet B-celle lymfom

/ Martin Hutchings
Lymfom Play the Video
Carsten Utoft Niemann

Tidsbegrænset venetoclax-baseret kombinationsbehandling opnår bedre PFS og MRD-negativitet ved behandling af CLL

/ Carsten Utoft Niemann
CLL Play the Video
Martin Hutchings

Hidtil højeste overall survival udfordrer 1.-linjebehandling ved Hodgkin lymfom

/ Martin Hutchings
Lymfom Play the Video

Gå ikke glip af det nyeste fra Hæmatologi

Skriv dig på og få nye artikler, MEDtalks og magasiner i din indbakke

Send mig seneste nyt fra hæmatologi

Mere fra EHA 2022

Daniel Kristensen

Tillæg af andengenerations-FLT3-inhibitor til intensiv kemoterapi og konsolidering hos voksne med AML

/ Daniel Kristensen
EHA22AML Play the Video
Agoston Gyula Szabo

Værdien af højdosisbehandling som tillæg til Rvd induktion og konsolidering ved myelomatose

/ Agoston Gyula Szabo
EHA22Myelomatose Play the Video
Carsten Utoft Niemann

Sekventering og vurdering af behandlingsforløb ved CLL

/ Carsten Utoft Niemann
EHA22CLL Play the Video

Mere fra EHA 2021

Significant improvements in OS and RFS for older patients with AML

/ Farhad Ravandi
EHA21AML Play the Video

Iberdomide show promising efficacy in heavily pretreated patients with Relapsed/Refractory Multiple Myeloma

/ Sagar Lonial
EHA21Myelomatose Play the Video

Highlights fra EHA 2021 (2:2)

/ Fredrik Schjesvold / Agoston Gyula Szabo
EHA21Myelomatose Play the Audio

Highlights fra EHA 2021 (1:2)

/ Fredrik Schjesvold / Agoston Gyula Szabo
EHA21Myelomatose Play the Audio

EHA-ESMO Clinical Practice Guidelines for Multiple Myeloma

/ Fredrik Schjesvold
EHA21Myelomatose Play the Video

Potential to become the best treatment for multiple myeloma in history

/ Thierry Facon
EHA21Myelomatose Play the Video
Læs mere

New bispecific antibody with promising efficacy and safety profil for patients with relapsed/refractory Multiple Myeloma

/ Amrita Y. Krishnan
EHA21Myelomatose Play the Video

Azacitidin tolereredes generelt godt af ældre patienter med AML

/ BestPractice Nordic
AlderdomEHA21AML

First-in-human study of teclistamab for relapsed/refractory Multiple Myeloma

/ Niels van de Donk
EHA21Myelomatose Play the Video
Back to top